Search research articles
Contact Us
Filters
Showing results (141-150 of 724) with videos related to
Page
of 73
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association
|
October 12, 2018
Predictive factors of improvement for voiding symptoms after holmium laser enucleation of the prostate
Fukashi Yamamichi, Katsumi Shigemura, Koichi Kitagawa, et al.
Current Urology
|
June 12, 2014
Significance of ureteroscopic biopsy grade in patients with upper tract urothelial carcinoma
Junya Furukawa, Hideaki Miyake, Iori Sakai, et al.
Asian Journal of Andrology
|
July 5, 2014
Impact of penile rehabilitation with low-dose vardenafil on recovery of erectile function in Japanese men following nerve-sparing radical prostatectomy
Yuzo Nakano, Hideaki Miyake, Koji Chiba, et al.
Urologic Oncology
|
November 19, 2013
Expression of molecular markers associated with the mammalian target of rapamycin pathway in nonmetastatic renal cell carcinoma: Effect on prognostic outcomes following radical nephrectomy
Masatomo Nishikawa, Hideaki Miyake, Ken-ichi Harada, et al.
International Journal of Clinical Oncology
|
September 11, 2013
Assessment of efficacy, safety and quality of life of 55 patients with metastatic renal cell carcinoma treated with temsirolimus: a single-center experience in Japan
Hideaki Miyake, Ken-Ichi Harada, Masafumi Kumano, et al.
Current Urology
|
June 12, 2014
Significance of uracil/tegafur for preventing intravesical recurrence of non-muscle invasive urothelial carcinoma of the bladder
Ken-Ichi Harada, Hideaki Miyake, Tomoaki Terakawa, et al.
Urologic Oncology
|
January 29, 2014
Expression profile of CD44s, CD44v6, and CD44v10 in localized prostate cancer: effect on prognostic outcomes following radical prostatectomy
Hiromoto Tei, Hideaki Miyake, Ken-ichi Harada, et al.
Clinical and Experimental Nephrology
|
August 18, 2011
Long-term complete response to very-low-dose interleukin-2 therapy in patients with metastatic renal cell carcinoma: report of two cases
Ken-Ichi Harada, Hideaki Miyake, Toshifumi Kurahashi, et al.
International Journal of Clinical Oncology
|
December 27, 2011
Health-related quality of life in Japanese patients with metastatic renal cell carcinoma treated with sunitinib
Hideaki Miyake, Ken-Ichi Harada, Yuji Kusuda, et al.
Expert Opinion on Investigational Drugs
|
April 26, 2006
The potential of clusterin inhibiting antisense oligodeoxynucleotide therapy for prostate cancer
Hideaki Miyake, Isao Hara, Masato Fujisawa, et al.
Page
of 73
Search research articles
Search
Showing results (141-150 of 724) with videos related to
Sort By:
Page
of 73
International Journal of Urology : Official Journal of the Japanese Urological Association
|
October 12, 2018
Predictive factors of improvement for voiding symptoms after holmium laser enucleation of the prostate
Fukashi Yamamichi, Katsumi Shigemura, Koichi Kitagawa, et al.
Current Urology
|
June 12, 2014
Significance of ureteroscopic biopsy grade in patients with upper tract urothelial carcinoma
Junya Furukawa, Hideaki Miyake, Iori Sakai, et al.
Asian Journal of Andrology
|
July 5, 2014
Impact of penile rehabilitation with low-dose vardenafil on recovery of erectile function in Japanese men following nerve-sparing radical prostatectomy
Yuzo Nakano, Hideaki Miyake, Koji Chiba, et al.
Urologic Oncology
|
November 19, 2013
Expression of molecular markers associated with the mammalian target of rapamycin pathway in nonmetastatic renal cell carcinoma: Effect on prognostic outcomes following radical nephrectomy
Masatomo Nishikawa, Hideaki Miyake, Ken-ichi Harada, et al.
International Journal of Clinical Oncology
|
September 11, 2013
Assessment of efficacy, safety and quality of life of 55 patients with metastatic renal cell carcinoma treated with temsirolimus: a single-center experience in Japan
Hideaki Miyake, Ken-Ichi Harada, Masafumi Kumano, et al.
Current Urology
|
June 12, 2014
Significance of uracil/tegafur for preventing intravesical recurrence of non-muscle invasive urothelial carcinoma of the bladder
Ken-Ichi Harada, Hideaki Miyake, Tomoaki Terakawa, et al.
Urologic Oncology
|
January 29, 2014
Expression profile of CD44s, CD44v6, and CD44v10 in localized prostate cancer: effect on prognostic outcomes following radical prostatectomy
Hiromoto Tei, Hideaki Miyake, Ken-ichi Harada, et al.
Clinical and Experimental Nephrology
|
August 18, 2011
Long-term complete response to very-low-dose interleukin-2 therapy in patients with metastatic renal cell carcinoma: report of two cases
Ken-Ichi Harada, Hideaki Miyake, Toshifumi Kurahashi, et al.
International Journal of Clinical Oncology
|
December 27, 2011
Health-related quality of life in Japanese patients with metastatic renal cell carcinoma treated with sunitinib
Hideaki Miyake, Ken-Ichi Harada, Yuji Kusuda, et al.
Expert Opinion on Investigational Drugs
|
April 26, 2006
The potential of clusterin inhibiting antisense oligodeoxynucleotide therapy for prostate cancer
Hideaki Miyake, Isao Hara, Masato Fujisawa, et al.
Page
of 73